VIVUS Inc. (VVUS) Shares Spike Following FDA Approval - InvestingChannel

VIVUS Inc. (VVUS) Shares Spike Following FDA Approval

Shares of VIVUS Inc. (VVUS) gained more than 12% to $4.55 in morning trading on Thursday after the U.S. Food and Drug Administration approved the company’s new label impotence drug STENDRA, which cuts in half the time patients need to take the pill before engaging in sexual activity. Previously approved prescribing information recommended that patients […]

View the full post at: VIVUS Inc. (VVUS) Shares Spike Following FDA Approval